Whether youre in Virginia Beach, Richmond, or anywhere in between, our team is here for you
You can read the full article at Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial In a phase 3 trial conducted in Japan, the efficacy and safety of tirzepatide, a new medication for type 2 diabetes, were compared to dulaglutide
In addition to claims that compounded GLP-1s infringe on pharmaceutical companies' patents, the FDA expressed concern that because the administration doesn't regulate compounded drugs, these versions may not be as safe as the brand-name GLP-1s and could carry a risk of improper dosing
Since then, it has become wildly popular as a treatment for obesity and diabetes